Work

Fatigue, health-related quality-of-life and metabolic changes in men treated with enzalutamide or abiraterone acetate plus prednisone for metastatic castration-resistant prostate cancer: A randomised clinical trial (HEAT)

Year: 2022

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: European Journal of Cancer

DOI: 10.1016/j.ejca.2022.04.034

Authors: Klara K. Ternov, Jens Sønksen, Mikkel Fode, Henriette Lindberg, Caroline Kistorp, Rasmus Bisbjerg, Jens Faber, Tobias W. Klausen, Ganesh Palapattu, Peter B. Østergren

Institutions: University of Copenhagen, Copenhagen University Hospital, Herlev Hospital, Gentofte Hospital, Zealand University Hospital, Rigshospitalet, Michigan Medicine, Medical University of Vienna

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4282584352

FWCI: 2.529

Cites: 30

Cited by: 19

Related to: 10